| Department of Neurology |
| Neurology |
Lymphomas of the nervous system
Primary Nervous System Tumors |
Boston: Massachusetts General Hospital
Waltham: Mass General Waltham |
MD,Emory University School of Medicine
MPH,Harvard School of Public Health |
| Neurology, American Board of Psychiatry and Neurology |
| Male |
| Adult |
| Yes |
| View list » Aetna Health Inc.
Beech Street
Blue Cross Blue Shield - Blue Care 65
Blue Cross Blue Shield - Indemnity
Blue Cross Blue Shield - Managed Care
Blue Cross Blue Shield - Partners Plus
BMC HealthNet Mass Health MCO/ACO
Cigna (PAL #'s)
Commonwealth Care Alliance
Fallon Community HealthCare
Great-West Healthcare (formally One Health Plan)
Harvard Pilgrim Health Plan - ACD
Harvard Pilgrim Health Plan - PBO
Health Care Value Management (HCVM)
Humana/Choice Care PPO
MassHealth
Medicare
Medicare - ACD
Neighborhood Health Plan - ACD
Neighborhood Health Plan - PBO
OSW - Maine
OSW - New Hampshire
OSW - Rhode Island
Private Health Care Systems (PHCS)
Railroad Medicare
Railroad Medicare - ACD
Senior Whole Health
TriCare
Tufts Health Plan
Unicare
United Healthcare (non-HMO) - ACD
United Healthcare (non-HMO) - PBO
Well Sense Pediatrics « Hide list |
Dr. Tracy Batchelor received his undergraduate and medical degrees from Emory University as well as graduate degrees from Harvard University. He completed training in internal medicine at Yale-New Haven Hospital, neurology at Massachusetts General Hospital and neuro-oncology at Memorial Sloan-Kettering Cancer Center. He served as the chief resident in neurology in his final year of residency training at Mass General.
He joined the professional staff at Mass General in 1996 and served as Director of the Neuro-Oncology Fellowship Training Program from 1996-2006.
He has served as Executive Director of the Stephen E. and Catherine Pappas Center for Neuro-Oncology and Chief of the Division of Neuro-Oncology at Mass General Cancer Center since 2001.
He is currently a Professor of Neurology at Harvard Medical School.
Dr. Batchelor's research interests include the development of novel targeted therapeutics for glioblastomas and other primary tumors of the central nervous system.
Dr. Batchelor's main clinical interests include management of patients with primary tumors of the central nervous system including high-grade gliomas (glioblastoma, anaplastic astrocytoma, anaplastic oligodendroglioma, anaplastic ependymoma), low-grade gliomas (astrocytoma, oligodendroglioma, ependymoma), and primary CNS lymphomas.